Basic information Safety Supplier Related

Indisulam

Basic information Safety Supplier Related

Indisulam Basic information

Product Name:
Indisulam
Synonyms:
  • INDISULAM
  • 1,4-Benzenedisulfonamide, N-(3-chloro-1H-indol-7-yl)-
  • N-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide
  • E-7070
  • ER-35744
  • IndisulaM (E7070)
  • IndisulaM (E7070) (ER-35744)
  • N1-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide
CAS:
165668-41-7
MF:
C14H12ClN3O4S2
MW:
385.85
Mol File:
165668-41-7.mol
More
Less

Indisulam Chemical Properties

Melting point:
242-243 °C (decomp)(Solv: ethanol (64-17-5); water (7732-18-5))
Boiling point:
668.9±65.0 °C(Predicted)
Density 
1.663±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
DMSO : 100 mg/mL (259.17 mM; Need ultrasonic)
form 
powder
pka
8.14±0.30(Predicted)
color 
white to beige
InChI
InChI=1S/C14H12ClN3O4S2/c15-12-8-17-14-11(12)2-1-3-13(14)18-24(21,22)10-6-4-9(5-7-10)23(16,19)20/h1-8,17-18H,(H2,16,19,20)
InChIKey
SETFNECMODOHTO-UHFFFAOYSA-N
SMILES
C1(S(NC2C3=C(C=CC=2)C(Cl)=CN3)(=O)=O)=CC=C(S(N)(=O)=O)C=C1
More
Less

Indisulam Usage And Synthesis

Uses

Indisulam (E 7070) is a carbonic anhydrase inhibitor with anticancer activity. Indisulam (E 7070) is a sulfonamide agent that targets the G1 phase of the cell cycle. Indisulam (E 7070) causes a blockade in the G1/S transition through inhibition of the activation of both CDK2 and cyclin E. Indisulam (E 7070) targets splicing by inducing RBM39 degradation via recruitment to DCAF15[1][2].

Definition

ChEBI: Indisulam is a chloroindole that is 3-chloro-1H-indole substituted by a [(4-sulfamoylphenyl)sulfonyl]nitrilo group at position 7. It is a carbonic anhydrase inhibitor and a potential anti-cancer agent currently in clinical development. It has a role as an EC 4.2.1.1 (carbonic anhydrase) inhibitor and an antineoplastic agent. It is a chloroindole, a sulfonamide and an organochlorine compound.

Biochem/physiol Actions

Indisulam is a carbonic anhydrase inibitor and Antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

in vivo

Indisulam (E7070, 12.5, 25, 50 (100) mg/kg) shows an antitumour spectrum in human cancer models[1].

Animal Model:Female BALB/c nu/nu mice aged 7 weeks (HCT116 colon, LX-1 lung, SW620 colon, HCT115 colon, PC-9 lung, DLD-1 colon and WiDr colon models)[1].
Dosage:12.5, 25, 50 (100) mg/kg.
Administration:IV daily for 4 days.
Result:Exhibited anti-tumor activity.

storage

Store at -20°C

References

[1] Ozawa Y, et al. E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo. Eur J Cancer. 2001 Nov;37(17):2275-82. DOI:10.1016/s0959-8049(01)00275-1
[2] Abbate F, et al. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett. 2004 Jan 5;14(1):217-23. DOI:10.1016/j.bmcl.2003.09.062

IndisulamSupplier

InvivoChem Gold
Tel
13549236410
Email
sales@invivochem.cn
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Email
info@adooq.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Email
info@adooq.cn